Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jul-19 9:15 PM View:  | Revance Therapeutics, Inc. (RVNC) | 28-Jun-19 | Acquisition (other) | 1,000 | $11.02 | $11,024.50 | < 1% 151.6K to 152.6K | (< 1%) |
| 19-Mar-19 9:01 PM View: | Revance Therapeutics, Inc. (RVNC) | 18-Mar-19 | Market Sale (Planned) | 11,613 | $15.51 | $180,068.00 | (7%) 163.22K to 151.6K | (78%) |
| 19-Mar-19 9:01 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-19 | Payment of Exercise | 6,137 | $15.45 | $94,816.60 | (4%) 169.35K to 163.22K | (79%) |
| 20-Feb-19 9:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-Feb-19 | Market Sale (Planned) | 5,446 | $17.68 | $96,285.30 | (3%) 174.8K to 169.35K | (56%) |
| 20-Feb-19 9:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-19 | Payment of Exercise | 3,154 | $17.69 | $55,794.30 | (2%) 177.95K to 174.8K | (56%) |
| 25-Jan-19 9:02 PM View: | Revance Therapeutics, Inc. (RVNC) | 24-Jan-19 | Grant | 35,000 | -- | -- | 24% 142.95K to 177.95K | |
| 03-Jul-18 8:17 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Jun-18 | Acquisition (other) | 668 | $23.33 | $15,586.10 | < 1% 142.28K to 142.95K | |
| 16-Mar-18 8:03 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-18 | Option Exercise | 20,000 | $2.55 | $51,000.00 | 16% 127.74K to 147.74K | |
| 16-Mar-18 8:03 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-18 | Market Option Sale (Planned) | 5,452 | $31.43 | $171,348.00 | (4%) 147.74K to 142.28K | 12% |
| 16-Mar-18 8:03 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-18 | Payment of Exercise | 2,881 | $31.65 | $91,183.60 | (2%) 131.62K to 128.74K | 13% |
| 16-Mar-18 8:03 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-18 | Market Option Sale (Planned) | 1,000 | $32.80 | $32,800.00 | (< 1%) 128.74K to 127.74K | 16% |
| 09-Mar-18 8:36 PM View: | Revance Therapeutics, Inc. (RVNC) | 07-Mar-18 | Market Sale (Planned) | 27,283 | $31.43 | $857,505.00 | (17%) 158.9K to 131.62K | 12% |
| 16-Feb-18 7:42 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-18 | Payment of Exercise | 3,074 | $31.75 | $97,599.50 | (2%) 161.97K to 158.9K | 13% |
| 09-Feb-18 9:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 08-Feb-18 | Grant | 28,250 | -- | -- | 21% 133.72K to 161.97K | |
| 03-Jan-18 8:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Dec-17 | Acquisition (other) | 127 | $22.99 | $2,920.05 | < 1% 133.6K to 133.72K | |
| 24-Nov-17 4:06 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Nov-17 | Market Sale (Planned) | 7,600 | $24.94 | $189,570.00 | (5%) 141.2K to 133.6K | (11%) |
| 20-Oct-17 8:10 PM View: | Revance Therapeutics, Inc. (RVNC) | 18-Oct-17 | Market Sale (Planned) | 7,662 | $26.16 | $200,405.00 | (5%) 148.86K to 141.2K | (5%) |
| 22-Sep-17 8:08 PM View: | Revance Therapeutics, Inc. (RVNC) | 20-Sep-17 | Market Sale (Planned) | 7,600 | $23.58 | $179,185.00 | (5%) 156.46K to 148.86K | (17%) |
| 25-Aug-17 7:41 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Aug-17 | Option Exercise | 331 | $2.55 | $844.05 | < 1% 178.93K to 179.26K | |
| 25-Aug-17 7:41 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Aug-17 | Market Option Sale (Planned) | 331 | $22.76 | $7,535.05 | (< 1%) 179.26K to 178.93K | (21%) |
| 25-Aug-17 7:41 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Aug-17 | Market Sale (Planned) | 22,469 | $22.76 | $511,496.00 | (13%) 178.93K to 156.46K | (21%) |
| 05-Jul-17 9:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-17 | Acquisition (other) | 1,000 | $18.32 | $18,317.50 | < 1% 177.93K to 178.93K | |
| 14-Jun-17 8:11 PM View: | Revance Therapeutics, Inc. (RVNC) | 12-Jun-17 | Option Exercise | 8,300 | $2.55 | $21,165.00 | 5% 169.63K to 177.93K | |
| 31-May-17 9:38 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-May-17 | Option Exercise | 5,000 | $2.55 | $12,750.00 | 3% 164.63K to 169.63K | |
| 24-May-17 9:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 24-May-17 | Market Sale (Planned) | 19,713 | $20.35 | $401,091.00 | (11%) 184.34K to 164.63K | (36%) |
| 24-May-17 9:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-May-17 | Market Sale (Planned) | 12,287 | $20.20 | $248,159.00 | (6%) 196.63K to 184.34K | (37%) |
| 17-Mar-17 7:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Mar-17 | Payment of Exercise | 3,171 | $19.20 | $60,885.40 | (2%) 199.8K to 196.63K | (44%) |
| 24-Feb-17 9:04 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Feb-17 | Market Sale (Planned) | 11,037 | $20.57 | $227,050.00 | (5%) 210.84K to 199.8K | (34%) |
| 30-Jan-17 9:28 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-Jan-17 | Grant | 25,800 | -- | -- | 14% 185.04K to 210.84K | |
| 27-Jan-17 8:04 PM View: | Revance Therapeutics, Inc. (RVNC) | 25-Jan-17 | Market Sale (Planned) | 12,000 | $19.78 | $237,398.00 | (6%) 197.04K to 185.04K | (40%) |
| 03-Jan-17 5:52 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Dec-16 | Acquisition (other) | 1,000 | $11.58 | $11,577.00 | < 1% 196.04K to 197.04K | |
| 30-Dec-16 6:38 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Dec-16 | Market Sale (Planned) | 12,000 | $20.94 | $251,250.00 | (6%) 208.04K to 196.04K | (32%) |
| 25-Nov-16 9:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 25-Nov-16 | Market Sale (Planned) | 12,000 | $17.92 | $215,005.00 | (5%) 220.04K to 208.04K | (39%) |
| 28-Oct-16 9:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-Oct-16 | Market Sale (Planned) | 12,000 | $14.85 | $178,199.00 | (5%) 232.04K to 220.04K | (64%) |
| 23-May-16 9:28 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-May-16 | Payment of Exercise | 12,050 | $17.11 | $206,176.00 | (5%) 244.09K to 232.04K | (43%) |
| 11-Feb-16 8:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Feb-16 | Grant | 25,000 | -- | -- | 11% 219.09K to 244.09K | |
| 04-Jan-16 9:10 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-15 | Acquisition (other) | 262 | $27.00 | $7,074.00 | < 1% 218.82K to 219.09K | |
| 04-Jan-16 9:10 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Dec-15 | Option Exercise | 12,045 | $2.55 | $30,714.80 | 6% 206.78K to 218.82K | |
| 02-Jul-15 8:35 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-15 | Acquisition (other) | 1,000 | $14.16 | $14,160.00 | < 1% 205.78K to 206.78K | |
| 21-May-15 6:46 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-May-15 | Payment of Exercise | 12,025 | $25.94 | $311,928.00 | (6%) 217.8K to 205.78K | 6% |
| 30-Jan-15 7:09 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jan-15 | Grant | 43,500 | -- | -- | 25% 174.03K to 217.53K | |
| 01-Dec-14 9:26 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Nov-14 | Market Purchase | 6,000 | $16.67 | $100,019.00 | 4% 168.03K to 174.03K | 46% |
| 21-May-14 9:30 PM View: | Revance Therapeutics, Inc. (RVNC) | 19-May-14 | Grant | 96,000 | $32.22 | $3,093,120.00 | 135% 71.03K to 167.03K | (24%) |
| 11-Feb-14 1:37 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Feb-14 | Conversion | 17,702 | -- | -- | 33% 53.33K to 71.03K |